OBJECTIVES: Diagnosis of unrecognized celiac disease is potentially important. The prevalence of celiac disease in patients with insulin-dependent diabetes mellitus is uncertain. We report the prevalence of celiac disease in a stratified random sample (n = 101) of adult insulin-dependent diabetic patients (age, 18-59 yr) attending our clinic, and in an age- and sex-matched control group (n = 51). METHODS: Screening was by anti-endomysial antibody, measured by indirect immunofluorescence using sections of human umbilical cord. RESULTS: Celiac disease had not been suspected in any patient at the time of screening. Eight patients tested positive for anti-endomysial antibody, all of whom had a distal duodenal biopsy performed. Five patients had histologic evidence of celiac disease. One patient with negative histology was receiving immunosuppressive therapy for a renal-pancreas transplant. Of the five patients with abnormal histology, two improved on gluten restriction, one was unable to comply, one refused treatment, and one was lost to follow-up. No control subject tested positive for endomysial antibody. CONCLUSIONS: Patients with insulin-dependent diabetes have an increased prevalence of celiac disease. Because most cases are clinically unrecognized, consideration should be given to screening all insulin-dependent diabetes mellitus patients with endomysial antibodies.
OBJECTIVES: Diagnosis of unrecognized celiac disease is potentially important. The prevalence of celiac disease in patients with insulin-dependent diabetes mellitus is uncertain. We report the prevalence of celiac disease in a stratified random sample (n = 101) of adult insulin-dependent diabeticpatients (age, 18-59 yr) attending our clinic, and in an age- and sex-matched control group (n = 51). METHODS: Screening was by anti-endomysial antibody, measured by indirect immunofluorescence using sections of human umbilical cord. RESULTS:Celiac disease had not been suspected in any patient at the time of screening. Eight patients tested positive for anti-endomysial antibody, all of whom had a distal duodenal biopsy performed. Five patients had histologic evidence of celiac disease. One patient with negative histology was receiving immunosuppressive therapy for a renal-pancreas transplant. Of the five patients with abnormal histology, two improved on gluten restriction, one was unable to comply, one refused treatment, and one was lost to follow-up. No control subject tested positive for endomysial antibody. CONCLUSIONS:Patients with insulin-dependent diabetes have an increased prevalence of celiac disease. Because most cases are clinically unrecognized, consideration should be given to screening all insulin-dependent diabetes mellituspatients with endomysial antibodies.
Authors: A Picarelli; L Sabbatella; M Di Tola; S Vetrano; C Casale; M C Anania; B Porowska; M Vergari; R Schiaffini; P Gargiulo Journal: Clin Exp Immunol Date: 2005-10 Impact factor: 4.330
Authors: S Garud; D Leffler; M Dennis; J Edwards-George; D Saryan; S Sheth; D Schuppan; S Jamma; C P Kelly Journal: Aliment Pharmacol Ther Date: 2009-04-15 Impact factor: 8.171
Authors: Toufic A Kabbani; Ciaran P Kelly; Rebecca A Betensky; Joshua Hansen; Kumar Pallav; Javier A Villafuerte-Gálvez; Rohini Vanga; Rupa Mukherjee; Aileen Novero; Melinda Dennis; Daniel A Leffler Journal: Gastroenterology Date: 2013-01-24 Impact factor: 22.682
Authors: K T Park; Raymond Tsai; Louise Wang; Nasim Khavari; Laura Bachrach; Dorsey Bass Journal: Clin Gastroenterol Hepatol Date: 2013-01-26 Impact factor: 11.382